Subscribe
Komsan Loonprom / Shutterstock.com
7 January 2025NewsAmericasMuireann Bolger

Tissue repair VP gets new trial over secrets damages

Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated secrets and breached contract | Companies in dispute process and manufacture medical products derived from human placental tissue.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Gene tech firm fends off injunction in test kit dispute
28 November 2024   New England Biolab contends plaintiff’s patents are invalid and cover “unpatentable natural processes”| Biomodal had accused rival of infringing several patents covering methods to detect and modify DNA methylatian—a key part of epigenetic research


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
Gene tech firm fends off injunction in test kit dispute
28 November 2024   New England Biolab contends plaintiff’s patents are invalid and cover “unpatentable natural processes”| Biomodal had accused rival of infringing several patents covering methods to detect and modify DNA methylatian—a key part of epigenetic research

More on this story

Americas
Gene tech firm fends off injunction in test kit dispute
28 November 2024   New England Biolab contends plaintiff’s patents are invalid and cover “unpatentable natural processes”| Biomodal had accused rival of infringing several patents covering methods to detect and modify DNA methylatian—a key part of epigenetic research

More features

Labcorp's bid to invalidate Ravgen's DNA testing patent hits roadblock
Troutman Pepper Locke exodus sees teams leave in Chicago and London
Ex-Baker McKenzie patent litigation head joins Morgan Lewis in Germany
Mitsubishi Tanabe takes on Indian generic drugmaker’s ALS application
Outlook for 2025: how Trump and the USPTO will affect life sciences IP
Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office